Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

235 works

Work: Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

  1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

    F. Stephen Hodi, Steven O’Day, David F. McDermott +26

    Article20109 citations
    ABI

  2. Cancer Statistics, 2021

    Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs +1

    Article20217 citations
    ABI

  3. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer

    Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6

    Review article20216 citations
    ABI

  4. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

    Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda +27

    Article20135 citations
    ABI

  5. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

    Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12

    Article20215 citations
    ABI

  6. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

    Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7

    Review article20195 citations
    ABI

  7. EP4 receptor as a novel promising therapeutic target in colon cancer

    Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5

    Review article20205 citations
    ABI

  8. The role of Th17 cells in the pathogenesis and treatment of breast cancer

    Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5

    Review article20225 citations
    ABI

  9. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

    Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11

    Article20245 citations
    ABI

  10. Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles

    Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11

    Article20224 citations
    ABI

  11. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

    Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

    Article20234 citations
    ABI

  12. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

    Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo +13

    Article20064 citations
    ABI

  13. RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression

    Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11

    Article20214 citations
    ABI

  14. Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art

    Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary +4

    Review article20234 citations
    ABI

  15. CTLA-4 and PD-1 Pathways

    Elizabeth I. Buchbinder, Anupam M. Desai

    Review article20153 citations
    ABI

  16. Role of the Microbiota in Immunity and Inflammation

    Yasmine Belkaid, Timothy W. Hand

    Review article20143 citations
    ABI

  17. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer

    Dariusz Waniczek, Zbigniew Lorenc, Mirosław Śnietura +3

    Article20173 citations
    ABI

  18. Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

    Andrea Nicolini, Paola Ferrari

    Review article20243 citations
    ABI

  19. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges

    Frans V. Suurs, Marjolijn N. Lub–de Hooge, Elisabeth G.E. de Vries +1

    Review article20192 citations
    ABI

  20. VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

    Magali Terme, Simon Pernot, Elie Marcheteau +7

    Article20122 citations
    ABI

  21. Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

    Peter Attia, Ajay V. Maker, Leah Haworth +2

    Article20052 citations
    ABI

  22. Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

    Gabriela Bindea, Bernhard Mlecnik, Marie Tosolini +14

    Article20132 citations
    ABI

  23. The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

    Nicolás J. Llosa, Michael Cruise, Ada Tam +15

    Article20142 citations
    ABI

  24. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

    David G. DeNardo, Lisa M. Coussens

    Review article20072 citations
    ABI

  25. Microenvironmental regulation of metastasis

    Johanna A. Joyce, Jeffrey W. Pollard

    Review article20082 citations
    ABI